Objectives: Tendon and ligament pathology has been managed successfully with mesenchymal stem cells from various biological sources. This retrospective study aims to evaluate the re-injury rate of the treatment of tendon and ligament lesions with allogenic bone marrow derived mesenchymal stem cells (BM-MSCs). Methods: Data from horses treated with allogenic BM- MSCs was recovered retrospectively from hospital r...